ENO2 and small cell lung carcinoma: LDH expression in serum was also demonstrated to be a predicting factor for therapy response and survival of SCLC patients treated with chemotherapy in other studies.[28–30] Our study revealed that lower serum levels of NSE and LDH in SCLC patients were associated with better therapy response and survival; those data were broadly in line with this study.